Moolec Science Regains Nasdaq Compliance, Reports Increased Equity
MLEC has more than doubled off its 52-week low of $3.077.
Summary
Moolec Science SA announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement, reporting increased equity to $15.2 million as of March 31, 2026.
Key Events · Corporate Governance and Compliance · MLEC
-
Regains Nasdaq Compliance
Moolec Science SA has submitted information to Nasdaq demonstrating compliance with the minimum stockholders' equity requirement, resolving a previously reported non-compliance issue.
-
Increased Stockholders' Equity
Stockholders' equity rose to approximately $15.2 million as of March 31, 2026, up from $11.3 million as of December 31, 2025.
-
Preference Share Conversion
The increase in equity was partly due to the partial conversion of preference shares totaling $5.47 million into ordinary shares as of December 31, 2025.
-
Future Equity Strengthening
The company expects to convert the remaining $4.0 million of preference shares within the next 12 months, which is anticipated to further strengthen stockholders' equity.
Analysis · MLEC · Manufacturing
Moolec Science SA has successfully demonstrated compliance with Nasdaq's minimum stockholders' equity requirement, avoiding potential delisting. The company reported an increase in stockholders' equity to $15.2 million as of March 31, 2026, up from $11.3 million at year-end 2025, primarily driven by the conversion of preference shares. This resolution removes a significant overhang and strengthens the company's financial position.
At the time of this filing, MLEC was trading at $8.34 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $3.08 to $157.05. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.